My top 10 things to watch Friday, Oct. 3 1. Boeing problems: The planemaker's new 777X widebody jet is now set to make its commercial debut in early 2027 instead of next year, Bloomberg reported this morning. That delay could expose Club name Boeing to sizable non-cash accounting charges. Safety certification work is taking longer than expected. 2. BlackRock's Global Infrastructure Partners is seemingly negotiating to buy everything. This time, GIP is in talks to buy Aligned Data Centers in a transaction va ...

Key TakeawaysThe U.S. Bureau of Labor Statistics has delayed the release of the critical September Nonfarm Payrolls report due to the ongoing government shutdown, leaving markets without a key economic indicator.J.P. Morgan has significantly raised its price target for electric vehicle giant Tesla (TSLA) to $150.00 from $115.00.Wells Fargo has issued a "buy" rating for Johnson & Johnson (JNJ), driven by continued improvements in the company's drug sales.Political leaders continue to grapple with the shutdow ...

Core Insights - Artificial intelligence (AI) is identified as the greatest investment opportunity of the current era, with a strong emphasis on the urgency to invest in AI technologies now [1][13] - The energy demands of AI technologies are highlighted, with data centers consuming as much energy as small cities, leading to concerns about power grid strain and rising electricity prices [2][3] Investment Opportunity - A specific company is presented as a key player in the AI energy sector, owning critical energy infrastructure assets that are essential for supporting the anticipated surge in energy demand from AI data centers [3][7] - This company is characterized as a "toll booth" operator in the AI energy boom, benefiting from the increasing need for energy as AI technologies expand [4][5] Market Position - The company is noted for its unique position in the market, being debt-free and holding a significant cash reserve that is nearly one-third of its market capitalization [8] - It also has a substantial equity stake in another AI-related company, providing investors with indirect exposure to multiple growth engines in the AI sector [9][10] Strategic Advantages - The company is involved in large-scale engineering, procurement, and construction (EPC) projects across various energy sectors, including nuclear energy, which is crucial for America's future power strategy [7][8] - The current political climate, particularly Trump's tariffs and the push for onshoring, positions this company favorably to capitalize on domestic manufacturing and energy needs [5][14] Future Outlook - The influx of talent into the AI sector is expected to drive rapid advancements and innovation, reinforcing the importance of investing in AI-related companies [12] - The potential for significant returns is emphasized, with projections suggesting a possible 100% return within 12 to 24 months for investors who act now [15][19]

We recently published 5 Stocks That Were On Jim Cramer’s Radar As He Discussed AI. Johnson & Johnson (NYSE:JNJ) is one of the stocks Jim Cramer recently discussed. Johnson & Johnson (NYSE:JNJ) is one of the most diversified healthcare companies in the world. The firm operates in the pharmaceutical, medical devices, and other industries. Cramer previously discussed the stock on September 11th, when he wondered whether the major “litigation overhang” surrounding the firm actually involved an “overplayed” ha ...

Group 1: AI Investment Opportunity - Artificial intelligence is considered the greatest investment opportunity of our lifetime, with a strong emphasis on the urgency to invest now [1] - Wall Street is investing hundreds of billions into AI, but there is a critical question regarding the energy supply needed to support this technology [2] - AI data centers consume as much energy as small cities, leading to concerns about power grid strain and rising electricity prices [2] Group 2: Company Overview - A specific company, largely overlooked by AI investors, is positioned to benefit from the increasing demand for energy due to AI [3] - This company owns critical energy infrastructure assets and is involved in the U.S. LNG exportation sector, which is expected to grow under the current administration's energy policies [7] - The company is debt-free and has a significant cash reserve, amounting to nearly one-third of its market cap, making it financially robust [8] Group 3: Market Position and Valuation - The company is trading at less than 7 times earnings, which is considered undervalued given its ties to both AI and energy sectors [10] - It also holds a substantial equity stake in another AI-related company, providing indirect exposure to multiple growth engines without a premium [9] - Wall Street is beginning to take notice of this company as it benefits from various market trends without the high valuations typical of the sector [8] Group 4: Future Outlook - The future of AI is heavily reliant on energy infrastructure, and this company is strategically positioned to capitalize on the upcoming energy demands [6][14] - The influx of talent into the AI sector ensures continuous innovation and advancements, further solidifying the importance of investing in AI-related companies [12] - The overall sentiment is that investing in AI now is crucial for future growth and returns, with potential for significant upside within the next 12 to 24 months [15]

(Reuters) -Global drugmakers are scrambling to shore up their U.S. manufacturing capacity and domestic inventory as the Trump administration moves ahead with a 100% tariff on imported branded and patented drugs, starting October 1. The sweeping measure has triggered a flurry of activity across the industry, including fast-tracking U.S. manufacturing projects, price cuts and direct-to-consumer sales. Here's what drugmakers are doing to mitigate supply-chain risks and reassure investors: Pfizer Pfizer re ...

Johnson & Johnson (NYSE:JNJ) is one of the stocks Jim Cramer shared his take on. Cramer appreciated the company’s research and products during the episode, as he commented: “Even though it’s been a terrible year for healthcare stocks, there are still a handful of real winners like Johnson and Johnson, up more than 24% year to date. I think that’s because of their incredible research work and their remarkable pipeline. It’s differentiating itself from the pack.” Stock market data showing an upward traje ...

IRVINE, CALIFORNIA - OCTOBER 17: The Johnson & Johnson logo is displayed at company offices on October 17, 2023 in Irvine, California. Johnson & Johnson beat Wall Street’s quarterly revenue and earnings estimates as sales in its pharmaceutical and medical devices businesses grew. (Photo by Mario Tama/Getty Images)Getty ImagesOver the past ten years, Johnson & Johnson (NYSE: JNJ) has delivered an impressive $157 Bil back to its investors through cash distributions via dividends and buybacks. This commitment ...

Jorja Johnson (L) gets a reaction from her brother JW Johnson (R) on this flying backhand overhead attempt.PPALast weekend, the Professional Pickleball Association (PPA) held an event that usually is only the subject of “what-if” arguments made by diehard fans sitting at a bar: what would happen if every player was forced to play with the same equipment, completely leveling the playing field in a professional sport and nullifying any advantage borne by the equipment advances we’ve seen over the past few yea ...

Johnson & Johnson (NYSE:JNJ) is included among the 10 Best Recession Proof Dividend Stocks to Buy. Johnson & Johnson (JNJ): A Dividend Aristocrat With Unmatched Stability Johnson & Johnson (NYSE:JNJ), founded in 1886 to produce sterile surgical supplies after the Civil War, has since grown into one of the largest global pharmaceutical and medical device companies. Unlike some drugmakers that rely heavily on a single blockbuster treatment, Johnson & Johnson (NYSE:JNJ) maintains a diverse portfolio across ...